Newron Pharmaceuticals – equity proposition

Newron Pharmaceuticals – equity proposition

Newron Pharmaceuticals — 4 videos in collection

More on this equity

Newron Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for central nervous system disorders. The company is progressing its lead asset, evenamide, through late-stage development for treatment-resistant schizophrenia (TRS), a disease area that has seen limited innovation in recent years and therefore presents a potentially sizeable commercial opportunity.

We highlight five key reasons why Newron may be considered a compelling investment opportunity:

  1. Evenamide addresses a major unmet need in healthcare.
  2. Evenamide is supported by encouraging clinical data in TRS.
  3. A defined registrational pathway provides near-term catalysts.
  4. Strategic partnerships provide external validation of evenamide’s potential.
  5. The company has proven commercial capabilities.

To learn more about Newron Pharmaceuticals, see our latest research.


You may also be interested in these:

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.